Technical Analysis for HRTX - Heron Therapeutics, Inc.

Grade Last Price % Change Price Change
B 18.08 -0.44% -0.08
HRTX closed down 0.44 percent on Thursday, April 22, 2021, on 79 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
Earnings due: May 4
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical HRTX trend table...

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
Overbought Stochastic Strength 0.00%
Pocket Pivot Bullish Swing Setup -0.44%
Overbought Stochastic Strength -0.44%
Crossed Above 50 DMA Bullish 1.69%
180 Bullish Setup Bullish Swing Setup 1.69%
Pocket Pivot Bullish Swing Setup 1.69%
Overbought Stochastic Strength 1.69%
Fell Below 50 DMA Bearish 5.42%
Stochastic Sell Signal Bearish 5.42%
Older End-of-Day Signals for HRTX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible NR7 about 14 hours ago
60 Minute Opening Range Breakout about 16 hours ago
Rose Above Previous Day's High about 19 hours ago
Up 1% about 19 hours ago
Up 1% 1 day ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Heron Therapeutics, Inc. Description

Heron Therapeutics, Inc., a specialty pharmaceutical company, develops product candidates using its proprietary Biochronomer polymer-based drug delivery platform. The company's drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that should be injected once or twice per day to products that need to be injected once every one or two weeks. Its lead product candidate, Sustol, is developed for the prevention of both acute- and delayed-onset chemotherapy-induced nausea and vomiting for patients undergoing emetogenic chemotherapy. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in Redwood City, California.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Clinical Medicine Pharmaceutical Oncology Cancer Treatments Chemotherapy Occupational Safety And Health Drug Delivery Antineoplastic Drugs Nausea

Is HRTX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 22.4
52 Week Low 12.52
Average Volume 989,519
200-Day Moving Average 16.97
50-Day Moving Average 17.14
20-Day Moving Average 16.77
10-Day Moving Average 17.36
Average True Range 0.77
ADX 16.76
+DI 24.89
-DI 15.85
Chandelier Exit (Long, 3 ATRs ) 16.18
Chandelier Exit (Short, 3 ATRs ) 16.66
Upper Bollinger Band 18.63
Lower Bollinger Band 14.92
Percent B (%b) 0.85
BandWidth 22.15
MACD Line 0.32
MACD Signal Line 0.10
MACD Histogram 0.2172
Fundamentals Value
Market Cap 1.64 Billion
Num Shares 90.6 Million
EPS -2.56
Price-to-Earnings (P/E) Ratio -7.06
Price-to-Sales 15.75
Price-to-Book 5.90
PEG Ratio -0.18
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 18.79
Resistance 3 (R3) 18.85 18.67 18.67
Resistance 2 (R2) 18.67 18.49 18.64 18.63
Resistance 1 (R1) 18.38 18.38 18.29 18.32 18.59
Pivot Point 18.20 18.20 18.16 18.17 18.20
Support 1 (S1) 17.91 18.02 17.82 17.85 17.57
Support 2 (S2) 17.73 17.91 17.70 17.53
Support 3 (S3) 17.44 17.73 17.49
Support 4 (S4) 17.38